BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

Vaccinex, Inc

Vaccinex, Inc. is a biotechnology company engaged in the discovery and development of human antibodies into novel therapeutic drugs to treat a variety of diseases. Our proprietary ACTIVMAB antibody discovery technology allows for the direct selection of high affinity, fully human monoclonal antibodies that would be difficult or impossible to identify using other systems. Unique to this technology is the capability to recover fully functional human antibodies from libraries expressed in mammalian cells.
Vaccinex is commercializing the ACTIVMAB technology by discovering antibodies for the development of our own in-house pipeline of therapeutic antibodies, for antibody co-development partners, and for client companies needing fee-based research services. This strategy allows Vaccinex to generate near-term collaboration revenues to offset operating costs, while building long-term value through the development of a broad pipeline of therapeutic antibody products. The company’s current antibody drug development efforts are focused on cancer, autoimmune and inflammatory diseases. Vaccinex’s most advanced product candidate is C35, a proprietary antibody for the treatment of breast cancer.


Contact Details:
1895 Mt. Hope Avenue
Rochester
New York
14620
United States of America
Tel:585-271-2700
Fax:585-271-2766
Email:info@vaccinex.com
WWW:

www.vaccinex.com/




Loading...

BioNews Results for Vaccinex, Inc:

DATATRAK Announces Next Release of eClinical Product Suite
Applied Clinical Trials:  Oct 5 2008 7:53AM Matching: inc
Anika Therapeutics Announces Exclusive Canadian Distribution Agreement for ELEVESS(R) with Canderm Pharma Inc
SmartBrief:  Oct 5 2008 5:39AM Matching: inc
Connecticut Technology Council Announces UHY LLP Tech Top 40 Winners
KRON4:  Oct 4 2008 6:17AM Matching: inc
Connecticut Technology Council Announces UHY LLP Tech Top 40 Winners
KSLA:  Oct 4 2008 12:09AM Matching: inc
Connecticut Technology Council Announces UHY LLP Tech Top 40 Winners
KOTA Territory News:  Oct 4 2008 4:43AM Matching: inc
Promote your company here: BioNewsCast - Press Release Distribution

View more Vaccinex, Inc news.

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 226 times since April 2007, the link to the organisation's website has been followed 38 times

Recent Search Terms used to find this page: t | ActivMAb | .

Search for more companies in Rochester

Search for more companies in New York



This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for Vaccinex, Inc
 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright 1997-2008 - BioPortfolio Limited.